Welcome to the e-CCO Library!

OP03: Reduced need for surgery and medical therapy after early ileocaecal resection for Crohn’s Disease: Long-term follow up of the LIR!C trial
Year: 2020
Source: ECCO'20 Vienna
Authors: Toer Stevens
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
OP03: Standardized faecal microbiota transplantation with microbiome-guided donor selection in active UC patients: A randomized, placebo-controlled intervention study
Year: 2022
Source: ECCO'22
Authors: Caenepeel, C.(1,2);Deleu, S.(1);Arnauts, K.(1);Vazquez Castellanos, J.F.(3);Braekeleire, S.(1);Machiels, K.(1);Baert, F.(4);Mana, F.(5);Pouillon, L.(6);Hindryckx, P.(7);Lobaton, T.(7);Louis, E.(8);Franchimont, D.(9);Ferrante, M.(1,2);Sabino, J.(1,2);Vieira-Silva, S.(3);Falony, G.(3);Raes, J.(3);Vermeire, S.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
OP04 Long-term outcomes after ileocolonic resection in Crohn’s disease according to the severity of early endoscopic recurrence
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Hammoudi1, C. Auzolle1, M.L. Tran Minh1, G. Boschetti2, M. Bezault3, A. Buisson4, B. Pariente5, X. Treton6, P. Seksik7, M. Fumery8, L. Le Bourhis9, S. Nancey2, M. Allez1, REMIND Study Group

Created: Thursday, 30 January 2020, 10:12 AM
OP04: Efficacy of upadacitinib in ulcerative colitis: A phase 3 post hoc analysis of biologic- and anti-TNF-inadequate response patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Séverine Vermeire
Created: Friday, 14 July 2023, 2:22 PM
OP04: Efficacy of upadacitinib in ulcerative colitis: A phase 3 post hoc analysis of biologic- and anti-TNF-inadequate response patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vermeire, S.(1)*;Danese, S.(2);Hébuterne, X.(3);D'Haens, G.(4);Takeuchi, K.(5);Finney-Hayward, T.(6);Klaff, J.(6);Holweg, C.T.J.(6);Rubin, D.T.(7);
Created: Friday, 14 July 2023, 10:43 AM
OP04: Long-term outcomes after ileocolonic resection in Crohn’s Disease according to severity of early endoscopic recurrence
Year: 2020
Source: ECCO'20 Vienna
Authors: Nassim Hammoudi
Created: Tuesday, 23 June 2020, 5:40 PM
OP04: Long-term outcomes after ileocolonic resection in Crohn’s Disease according to severity of early endoscopic recurrence
Year: 2020
Source: ECCO'20 Vienna
Authors: Nassim Hammoudi
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
OP04: Safety analysis of filgotinib for Ulcerative Colitis: Results from the phase 2b/3 SELECTION study and phase 3 SELECTIONLTE long-term extension study
Year: 2021
Source: ECCO'21 Virtual
Authors: Schreiber, S.W.(1);Watanabe, M.(2);Yun, C.(3);Zhou, Y.(3);Zhao, S.(3);Hsieh, J.(3);Moerch, U.(4);Rogler, G.(5);Loftus Jr, E.V.(6)
Created: Wednesday, 2 June 2021, 4:12 PM
OP04: Turning sweet in inflammatory bowel disease: glycans as novel immunomodulators of T-cell-mediated immune response
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Dias1, M. Pereira1, A. Correia1, I. Alves1, V. Pinto1, L. Azevedo2, L. Maia3, R. Marcos-Pinto3, M. Vilanova1, P. Lago3, S. Pinho*1

Created: Friday, 22 February 2019, 9:41 AM
OP04: Vedolizumab intravenous is effective across multiple treatment targets in chronic pouchitis: Results of the randomised, double-blind, placebo-controlled EARNEST trial
Year: 2022
Source: ECCO'22
Authors: Travis, S.(1);Silverberg, M.S.(2);Danese, S.(3);Gionchetti, P.(4);Löwenberg, M.(5);Jairath, V.(6,7);Feagan, B.G.(7);Bressler, B.(8);Lindner, D.(9);Escher, A.(9);Jones, S.(9);Shen, B.(10);
Created: Friday, 11 February 2022, 3:52 PM
OP05 Validation of the Lémann index in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B. Pariente1, J. Torres2, J. Burisch3, N. Arebi4, B. Barberio5, D. Duricova6, P. Ellul7, A. Goldis8, I. Kaimakliotis9, K. Katsanos10, Z. Krznaric11, D. Mc Namara12, N. Pedersen13, S. Sebastian14, P. Weimars15, P. Lung16, C. Lacognata17, M. Horak18, V. Domislovic11, I. Murphy12, R. Ungaro19, J.F. Colombel19, J.Y. Mary20

Created: Thursday, 30 January 2020, 10:12 AM
OP05: Association of ultra-processed food intake with risk of Inflammatory Bowel Disease from the prospective urban rural epidemiology (PURE) study: A prospective cohort study
Year: 2021
Source: ECCO'21 Virtual
Authors: Narula, N.(1);Wong, E.(1);Dehghan, M.(2);Mente, A.(2);Rangarajan, S.(2);Marshall, J.(1);Moayyedi, P.(1);Reinisch, W.(3);Yusuf, S.(2)
Created: Wednesday, 2 June 2021, 4:12 PM
OP05: Crohn’s disease exclusion diet is equally effective but better tolerated than exclusive enteral nutrition for induction of remission in mild-to-moderate active paediatric Crohn’s disease: a prospective randomised controlled trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Van Limbergen1,2, E. Wine3, A. Assa4, R. Sigall Boneh5, R. Shaoul6, M. Kori7, S. Cohen8, S. Peleg9, H. Shamaly10, A. On11, P. Milman12, L. Abramas5, T. Ziv Baran13, S. Grant14, A. Levine*5,13

Created: Friday, 22 February 2019, 9:41 AM
OP05: High-dimensional single-cell analysis identifies cellular signatures associated with response to vedolizumab therapy in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Paola Pibiri
Created: Friday, 14 July 2023, 2:22 PM
OP05: High-dimensional single-cell analysis identifies cellular signatures associated with response to vedolizumab therapy in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pibiri, P.(1)*;Sun, S.(1);Karmi, N.(1);Oelen, R.(2);de Jong, S.(1);Bangma, A.(1);Hermoso, M.(1);Paraskevopoulou, M.(3);Farahmand, S.(3);Weersma, R.(1);Bigaeva, E.(1);Festen, E.(1);Xia, G.(3);Teunis, J.(4);Bleck, B.(3);
Created: Friday, 14 July 2023, 10:43 AM
OP05: Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study
Year: 2022
Source: ECCO'22
Authors: Shavit, Z.(1);Stein, R.(2);Aloi, M.(3);Ledder, O.(4);Focht, G.(4);Urlep, D.(5);Hyams, J.(6);Broide, E.(7);Vais, B.(8);Levine, J.(9);Shouval , D.(10);Matar, M.(10);Assa, A.(10);Rosh, J.(11);Hussey, S.(12);Markowitz, J.(13);Yerushalmy-Feler, A.(14);Miele, E.(15);Shaoul, R.(16);Russell, R.K.(17);Turner, D.(4);
Created: Friday, 11 February 2022, 3:52 PM
OP05: Primary efficacy and safety of mirikizumab in moderate to severe Crohn’s Disease: results of the treat-through VIVID 1 study
Year: 2024
Source: ECCO'24 Stockholm
Authors: Ferrante, Marc
Created: Tuesday, 30 April 2024, 5:03 PM
OP05: Validation of the Lémann Index in Crohn’s Disease
Year: 2020
Source: ECCO'20 Vienna
Authors: Benjamin Pariente
Created: Tuesday, 23 June 2020, 5:40 PM
OP05: Validation of the Lémann Index in Crohn’s Disease
Year: 2020
Source: ECCO'20 Vienna
Authors: Benjamin Pariente
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1